Two Sigma Securities’s POMDOCTOR LIMITED Class A Ordinary Shares POM Stock Holding History

Two Sigma Securities’s Portfolio POM Stock Details POM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,491	Closed	-$39.2K	–	2568
2026 Q1	$39.2K	Buy	+8,491	New	+$43.5K	﹤0.01%	1293

Other funds holding POM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Two Sigma Securities's POM Position: Q2 2026 in Review

Two Sigma Securities sold out of POMDOCTOR LIMITED Class A Ordinary Shares (POM) in Q2 2026, closing a stake of 8,491 shares — an estimated $39.2K sold.

Two Sigma Securities first reported a position in POM in Q1 2026 and held it in 1 quarter. The position peaked at $39.2K in Q1 2026. 6 funds tracked by Wall St. Rank hold POM as of Q2 2026.

Two Sigma Securities reported no remaining POMDOCTOR LIMITED Class A Ordinary Shares position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 8,491 POMDOCTOR LIMITED Class A Ordinary Shares shares in Q2 2026, an estimated $39.2K.
Two Sigma Securities first reported a position in POMDOCTOR LIMITED Class A Ordinary Shares in Q1 2026 and held it in 1 quarter.
Two Sigma Securities's POMDOCTOR LIMITED Class A Ordinary Shares position peaked at $39.2K in Q1 2026.
6 funds tracked by Wall St. Rank held POMDOCTOR LIMITED Class A Ordinary Shares as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.